Trial Profile

Randomized pilot vs usual dose of lenalidomide dose reduction in patients with relapsed multiple myeloma who have reached maximum response. [No Ensayo piloto aleatorizado de dosis habitual de lenalidomida vs reducción de dosis en pacientes con mieloma múltiple en recaída que han alcanzado máxima respuesta]

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 22 Jul 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

02 Mar 2016 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
09 Jul 2015 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com